Journal of Clinical Oncology, Vol 17, Issue 10
(October), 1999: 3234-3237
© 1999 American Society for Clinical Oncology
Comparison of CSF Cytology and Spinal Magnetic Resonance Imaging in the Detection of Leptomeningeal Disease in Pediatric Medulloblastoma or Primitive Neuroectodermal Tumor
Maryam Fouladi,
Amar Gajjar,
James M. Boyett,
Andrew W. Walter,
Stephen J. Thompson,
Thomas E. Merchant,
Jesse J. Jenkins,
James W. Langston,
Aiyi Liu,
Larry E. Kun,
Richard L. Heideman
From the Departments of Hematology-Oncology, Radiation Oncology, Pathology and Laboratory Medicine, Biostatistics and Epidemiology, and Radiology, St Jude Children's Research Hospital; and Departments of Pediatrics, Radiation Oncology, and Radiology, University of Tennessee, College of Medicine, Memphis, TN.
Address reprint requests to Maryam Fouladi, MD, St Jude Children's Research Hospital; Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 N Lauderdale, Memphis, TN 38105; email maryam.fouladi{at}stjude.org
PURPOSE: Leptomeningeal disease (LMD) significantly affects the prognosis and treatment of pediatric patients with medulloblastoma or primitive neuroectodermal tumor (PNET). Examination of CSF for malignant cells, detection of LMD on spinal magnetic resonance imaging (MRI), or both are the methods routinely used to diagnose LMD. A recent study suggested 100% correlation between CSF and MRI findings in children with medulloblastoma. To determine the validity of this hypothesis, we compared the rate of detection of LMD between concurrent lumbar CSF cytology and spinal MRI performed at diagnosis in patients with medulloblastoma or PNET.
PATIENTS AND METHODS: As a part of diagnostic staging, 106 consecutive patients newly diagnosed with medulloblastoma or PNET were evaluated with concurrent lumbar CSF cytology and spinal MRI. CSF cytology was examined for the presence of malignant cells and spinal MRI was reviewed independently for the presence of LMD.
RESULTS: Thirty-four patients (32%) were diagnosed with LMD based on CSF cytology, spinal MRI, or both. There were 21 discordant results. Nine patients (8.5%) with positive MRI had negative CSF cytology. Twelve patients (11.3%) with positive CSF cytology had negative MRIs. The exact 95% upper bounds on the proportion of patients with LMD whose disease would have gone undetected using either CSF cytology or MRI as the only diagnostic modality were calculated at 14.4% and 17.7%, respectively.
CONCLUSION: With the use of either CSF cytology or spinal MRI alone, LMD would be missed in up to 14% to 18% of patients with medulloblastoma or PNET. Thus, both CSF cytology and spinal MRI should routinely be used to diagnose LMD in patients with medulloblastoma or PNET.
This article has been cited by other articles:

|
 |

|
 |
 
F. Yang, T. E. Van Meter, R. Buettner, M. Hedvat, W. Liang, C. M. Kowolik, N. Mepani, J. Mirosevich, S. Nam, M. Y. Chen, et al.
Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas
Mol. Cancer Ther.,
November 1, 2008;
7(11):
3519 - 3526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Oyharcabal-Bourden, C. Kalifa, J.C. Gentet, D. Frappaz, C. Edan, P. Chastagner, E. Sariban, A. Pagnier, A. Babin, F. Pichon, et al.
Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study
J. Clin. Oncol.,
July 20, 2005;
23(21):
4726 - 4734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Koeller and E. J. Rushing
From the Archives of the AFIP: Medulloblastoma: A Comprehensive Review with Radiologic-Pathologic Correlation
RadioGraphics,
November 1, 2003;
23(6):
1613 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Meyers, S. L. Wildenhain, J.-K. Chang, E. C. Bourekas, P. F. Beattie, D. N. Korones, D. Davis, I. F. Pollack, and R. A. Zimmerman
Postoperative Evaluation for Disseminated Medulloblastoma Involving the Spine: Contrast-enhanced MR Findings, CSF Cytologic Analysis, Timing of Disease Occurrence, and Patient Outcomes
AJNR Am. J. Neuroradiol.,
October 1, 2000;
21(9):
1757 - 1765.
[Abstract]
[Full Text]
|
 |
|
|